Drugs News and Research

RSS

Clinical trials show SGLT2 inhibitor may benefit patients with type 2 diabetes

Less than a decade ago, the Food and Drug Administration approved drugs for treating type 2 diabetes in an entirely new way.

16 Nov 2020

Combination of polypill and aspirin can reduce cardiovascular events by up to 40%

Heart attacks, strokes and other cardiovascular incidents can be cut by 20 to 40 per cent through use of a polypill which combines three blood pressure medications and a lipid lowering medication taken alone or with aspirin.

16 Nov 2020

New platform launched to advance worldwide antibiotic research and discovery

A network established by staff at the University of Plymouth has launched a new platform to push forward with worldwide antibiotic research and discovery.

16 Nov 2020

COVID-19 loneliness study reveals significant depressive symptoms in 80% of young adults

A new national survey, looking at how the COVID-19 pandemic has impacted young US adults' loneliness, reveals "significant depressive symptoms" in 80% of participants.

16 Nov 2020

First-ever phase 3 advanced anal cancer trial opens for patient enrollment

The first randomized phase 3 clinical trial ever to be conducted in patients with advanced cancer of the anal canal is now open and enrolling patients.

16 Nov 2020

Antifungal agent Itraconazole inhibits SARS CoV-2 in vitro

Itraconazole is a broad-spectrum antifungal agent that has been shown to have some in vitro activity against SARS-CoV-2 by a team of Belgian and German researchers.

16 Nov 2020

Care pathways for pregnant women with COVID‐19

A recent review published in the journal Global Challenges in October 2020, sums up what is currently known about the treatment of COVID-19 during pregnancy and offers recommendations for how healthcare professions might better manage pregnant COVID-19 patients in the future.

16 Nov 2020

STRENGTH trial: Fish oil-based medication did not decrease risk of cardiac events

The fish oil-based medication known as omega-3 carboxylic acids or omega-3 CA did not decrease the risk of cardiac events compared to a placebo, according to late-breaking research presented today at the American Heart Association's Scientific Sessions 2020.

16 Nov 2020

Short, one-month dual anti-platelet treatment is safe and effective after stent placement

A one-month treatment of dual anti-platelet therapy is safe and as effective as a longer duration of therapy at preventing cardiac events in patients one year after stent placement, according to late-breaking research presented today at the American Heart Association's Scientific Sessions 2020.

16 Nov 2020

Affinity-Bead Assisted Mass Spectrometry for Proteomics

In this interview, Ghaith Hamza from AstraZeneca talks to News-Medical Life Sciences about the basic principles of Affinity-Bead Assisted Mass Spectrometry (Affi-BAMS) and how Affi-BAMS can help target specific proteins for proteomic applications.

From Bruker Daltonics 16 Nov 2020

Omega-3 fatty acids did not reduce risk of cardiac events in elderly heart attack survivors

A daily dose of omega-3 fatty acids did not reduce the risk of cardiac events, including secondary heart attack, stroke, bypass surgery or death, among elderly people who had survived a recent heart attack, according to late-breaking research presented today at the American Heart Association's Scientific Sessions 2020.

16 Nov 2020

Research provides insight into how Alzheimer’s plaques form

We are beginning to better understand how 'amyloid-β' protein plaques form, which are implicated in degenerative brain diseases including Alzheimer's and Parkinson's diseases.

16 Nov 2020

Researchers explain why COVID-19 infects older people and spares younger children

Researchers at Vanderbilt University Medical Center (VUMC) and their colleagues have determined a key factor as to why COVID-19 appears to infect and sicken adults and older people preferentially while seeming to spare younger children.

16 Nov 2020

Royal Government of Cambodia commits to eliminating the deadliest strain of malaria

The Royal Government of Cambodia (RGC) today committed to eliminating Plasmodium falciparum within the next few months, and to maintaining zero cases by 2023, through the launch of an innovative and targeted approach for the ‘last mile’ of malaria elimination in the country.

16 Nov 2020

Antiviral immune response is suppressed in COVID-19 patients compared to flu patients

Rather than life-threatening hyperinflammation, most adults with moderate-to-severe COVID-19 have a suppressed viral immune response when compared to adults with another viral respiratory infection, influenza. St. Jude Children's Research Hospital and Washington University School of Medicine in St. Louis led research that suggests most COVID-19 patients are not candidates for treatment with steroids such as dexamethasone.

16 Nov 2020

CEAT project for improving ovarian cancer diagnosis, treatment shows promise

Porvair Sciences reports, due to promising results, it has agreed with its collaborative partners to make additional investment in the CEAT project which aims to dramatically improve the diagnosis and treatment of ovarian cancer.

From Porvair Sciences Limited 16 Nov 2020

New drug reduces LDL cholesterol in patients with severe hypercholesterolemia

The investigational drug evinacumab reduced low-density lipoprotein (LDL) cholesterol--the so-called "bad" cholesterol--by 50 percent in patients with severe hypercholesterolemia whose condition is resistant to standard treatments, a phase 2 study from the Icahn School of Medicine of Mount Sinai and other global academic sites has found.

16 Nov 2020

Drugs News and Research

Clinical trials show SGLT2 inhibitor may benefit patients with type 2 diabetes

Combination of polypill and aspirin can reduce cardiovascular events by up to 40%

New platform launched to advance worldwide antibiotic research and discovery

COVID-19 loneliness study reveals significant depressive symptoms in 80% of young adults

First-ever phase 3 advanced anal cancer trial opens for patient enrollment

Antifungal agent Itraconazole inhibits SARS CoV-2 in vitro

Care pathways for pregnant women with COVID‐19

STRENGTH trial: Fish oil-based medication did not decrease risk of cardiac events

Short, one-month dual anti-platelet treatment is safe and effective after stent placement

Affinity-Bead Assisted Mass Spectrometry for Proteomics

Omega-3 fatty acids did not reduce risk of cardiac events in elderly heart attack survivors

Research provides insight into how Alzheimer’s plaques form

Researchers explain why COVID-19 infects older people and spares younger children

Royal Government of Cambodia commits to eliminating the deadliest strain of malaria

Antiviral immune response is suppressed in COVID-19 patients compared to flu patients

CEAT project for improving ovarian cancer diagnosis, treatment shows promise

New drug reduces LDL cholesterol in patients with severe hypercholesterolemia

Tomocube’s HT-2 microscope quantifies therapeutic effects of targeted nanodrugs against atherosclerosis

Study explains why anti-inflammatory drugs benefit only few people with severe COVID-19

Prescription of antibiotics rises in England during COVID-19 lockdown

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News